Generation Bio Co (NAS:GBIO)
$ 2.64 -0.13 (-4.69%) Market Cap: 176.20 Mil Enterprise Value: 53.21 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 34/100

Generation Bio Co at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 07:50PM GMT
Release Date Price: $28.6 (+6.24%)
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team. Our next presenting company is Generation Bio. And speaking on behalf of the company, we have CEO, Geoff McDonough. Before I turn it over to Geoff, I just wanted to highlight, for those listening on the webcast, if you'd like to submit a question, please use, the ask a question, feature in the portal, and I'd be happy to ask -- and ask the question on your behalf.

With that, I'll turn it over to Geoff.

Cameron Geoffrey McDonough
Generation Bio Co. - President, CEO, Secretary & Director

Great. Thank you very much, Anupam, and thanks to you and to JPMorgan for hosting this great event. And also for the invitation to share with you a little bit about Generation Bio and what we're up to this year and in the years ahead. I'm going to start on Slide 1 by talking a little bit

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot